0001562180-16-003355.txt : 20161102
0001562180-16-003355.hdr.sgml : 20161102
20161102172534
ACCESSION NUMBER: 0001562180-16-003355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161031
FILED AS OF DATE: 20161102
DATE AS OF CHANGE: 20161102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TOTTEN POND ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 400 TOTTEN POND ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROYSTON IVOR
CENTRAL INDEX KEY: 0001026765
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 161969111
MAIL ADDRESS:
STREET 1: 4401 WILSHIRE BLVD.
STREET 2: SUITE 200
CITY: LOS ANGELES
STATE: CA
ZIP: 90010
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-10-31
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001026765
ROYSTON IVOR
C/O SYNDAX PHARMACEUTICALS, INC.
400 TOTTEN POND ROAD, SUITE 110
WALTHAM
MA
02451
true
false
false
false
Stock Option (Right to Buy)
11.81
2016-10-31
4
A
false
8000.00
0.00
A
2026-10-31
Common Stock
8000.00
8000.00
D
One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date.
/s/ Michael A. Metzger, Attorney-in-Fact
2016-11-02